Unusual 11 Mid-Day Movers 12/15: (SPMD) (OKSB) (ZOLL) Higher; (BPAX) (AIS) (ATHN) Lower
Tweet
Share
E-mail
Get Alerts BPAX Hot Sheet
Join SI Premium – FREE
BioSante (Nasdaq: BPAX) 76.9% LOWER; says Libegel did not meet primary, secondary endpoints. Click here for the full report. The stock was downgraded at JMP, Jefferies, Leerink Swann, Rodman & Renshaw and Roth Capital.
SuperMedia (Nasdaq: SPMD) 32.5% HIGHER; shares breaking above resistance around $2.50 and $3. Volume is very heavy and spiked notably after crossing the $3.50 level. Read about John Paulson's investment in the company here.
Antares Pharma (AMEX: AIS) 33.57% LOWER; in a partnership with BioSante for LibiGel. Roth Capital also downgraded the stock this morning.
Southwest Bancorp (Nasdaq: OKSB) 29.1% HIGHER; company entered into an agreement as of December 1, 2011 calling for a bulk sale for cash of loans and other real estate to SW Loan Portfolio Holdings, L.P. and its affiliates.
Zoll Medical (Nasdaq: ZOLL) 28.3% HIGHER; announces the CMS Durable Medical Equipment Medical Administrative Contractors reaffirmed the current coverage policy across all indications for the LifeVest(R) Wearable Defibrillator.
SonoSite (Nasdaq: SONO) 26.9% HIGHER; FUJIFILM announced it will acquire the company for $54 per share. Click here to see the full report.
athenahealth Inc. (Nasdaq: ATHN) 23.7% LOWER; sees FY12 adj-EPS of 85-97c on sales of $410-$430 million. The Street is looking for FY12 EPS of $1.16 on sales of $423.4 million. The guidance is coming from the company's annual investor summit.
Ampio Pharmaceuticals (Nasdaq: AMPE) 23.2% LOWER; shares continues its volatile streak this week after falling 32 percent on Tuesday and gaining back 20 percent yesterday. Shares are back below $5 today.
Pacific Ethanol (Nasdaq: PEIX) 19.5% LOWER; following a nearly 40 percent jump on December 1st and 2nd amid news of a new 7 percent stake in PE Holdco, the stock has tumbled nearly 53 percent since.
Cardiome Pharma (Nasdaq: CRME) 17.3% HIGHER; after trading up about 7 percent for most of today's session, the stock surged sharply after pushing over resistance at $2.
Novellus (Nasdaq: NVLS) 17.2% HIGHER; Lam Research (Nasdaq: LRCX) will acquire the company in a $3.3 billion all-stock deal. Novellus holders will get 1.125 shares of Lam for each share they hold. Click here to see the full report.
SuperMedia (Nasdaq: SPMD) 32.5% HIGHER; shares breaking above resistance around $2.50 and $3. Volume is very heavy and spiked notably after crossing the $3.50 level. Read about John Paulson's investment in the company here.
Antares Pharma (AMEX: AIS) 33.57% LOWER; in a partnership with BioSante for LibiGel. Roth Capital also downgraded the stock this morning.
Southwest Bancorp (Nasdaq: OKSB) 29.1% HIGHER; company entered into an agreement as of December 1, 2011 calling for a bulk sale for cash of loans and other real estate to SW Loan Portfolio Holdings, L.P. and its affiliates.
Zoll Medical (Nasdaq: ZOLL) 28.3% HIGHER; announces the CMS Durable Medical Equipment Medical Administrative Contractors reaffirmed the current coverage policy across all indications for the LifeVest(R) Wearable Defibrillator.
SonoSite (Nasdaq: SONO) 26.9% HIGHER; FUJIFILM announced it will acquire the company for $54 per share. Click here to see the full report.
athenahealth Inc. (Nasdaq: ATHN) 23.7% LOWER; sees FY12 adj-EPS of 85-97c on sales of $410-$430 million. The Street is looking for FY12 EPS of $1.16 on sales of $423.4 million. The guidance is coming from the company's annual investor summit.
Ampio Pharmaceuticals (Nasdaq: AMPE) 23.2% LOWER; shares continues its volatile streak this week after falling 32 percent on Tuesday and gaining back 20 percent yesterday. Shares are back below $5 today.
Pacific Ethanol (Nasdaq: PEIX) 19.5% LOWER; following a nearly 40 percent jump on December 1st and 2nd amid news of a new 7 percent stake in PE Holdco, the stock has tumbled nearly 53 percent since.
Cardiome Pharma (Nasdaq: CRME) 17.3% HIGHER; after trading up about 7 percent for most of today's session, the stock surged sharply after pushing over resistance at $2.
Novellus (Nasdaq: NVLS) 17.2% HIGHER; Lam Research (Nasdaq: LRCX) will acquire the company in a $3.3 billion all-stock deal. Novellus holders will get 1.125 shares of Lam for each share they hold. Click here to see the full report.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- AstraZeneca (AZN) shares jump on much stronger Q1 top and bottom line
- Meta Platforms, IBM, Caterpillar fall premarket; American Airlines, Chipotle rise
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Jefferies & Co, Roth Capital, Paulson & Co. (PCI), Rodman & Renshaw, Unusual 11 Mid-Day MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
